115 related articles for article (PubMed ID: 29243509)
1. Loss of MTAP expression is a negative prognostic marker in Ewing sarcoma family of tumors.
Abrahao-Machado LF; Antunes B; Filippi RZ; Volc S; Boldrini E; Menezes WP; Reis RM; de Camargo OP
Biomark Med; 2018 Jan; 12(1):35-44. PubMed ID: 29243509
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
[TBL] [Abstract][Full Text] [Related]
3. Expression of Methylthioadenosine Phosphorylase (MTAP) in Pilocytic Astrocytomas.
Becker AP; Scapulatempo-Neto C; Menezes WP; Clara C; Machado HR; Oliveira RS; Neder L; Reis RM
Pathobiology; 2015; 82(2):84-9. PubMed ID: 26088413
[TBL] [Abstract][Full Text] [Related]
4. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
[TBL] [Abstract][Full Text] [Related]
5. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
[TBL] [Abstract][Full Text] [Related]
6. MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients.
Su CY; Chang YC; Chan YC; Lin TC; Huang MS; Yang CJ; Hsiao M
Eur J Surg Oncol; 2014 Sep; 40(9):1143-50. PubMed ID: 24969958
[TBL] [Abstract][Full Text] [Related]
7. Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors.
Wild PJ; Meyer S; Bataille F; Woenckhaus M; Ameres M; Vogt T; Landthaler M; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
Arch Dermatol; 2006 Apr; 142(4):471-6. PubMed ID: 16618867
[TBL] [Abstract][Full Text] [Related]
8. Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.
Meyer S; Wild PJ; Vogt T; Bataille F; Ehret C; Gantner S; Landthaler M; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
Exp Dermatol; 2010 Aug; 19(8):e251-7. PubMed ID: 20500769
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumors.
López-Guerrero JA; Machado I; Scotlandi K; Noguera R; Pellín A; Navarro S; Serra M; Calabuig-Fariñas S; Picci P; Llombart-Bosch A
Int J Cancer; 2011 Mar; 128(5):1139-50. PubMed ID: 20473914
[TBL] [Abstract][Full Text] [Related]
10. Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma.
Sommer J; Itani DM; Homlar KC; Keedy VL; Halpern JL; Holt GE; Schwartz HS; Coffin CM; Kelley MJ; Cates JM
J Pathol; 2010 Apr; 220(5):608-17. PubMed ID: 20140939
[TBL] [Abstract][Full Text] [Related]
11. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.
Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ
Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653
[TBL] [Abstract][Full Text] [Related]
12. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumors.
Yabe H; Tsukahara T; Kawaguchi S; Wada T; Torigoe T; Sato N; Terai C; Aoki M; Hirose S; Morioka H; Yabe H
J Surg Oncol; 2011 Apr; 103(5):380-5. PubMed ID: 21400519
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.
Machado I; Yoshida A; López-Guerrero JA; Nieto MG; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2017 Sep; 213(9):1048-1053. PubMed ID: 28864350
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Features of the Non-CNS Primary Ewing Sarcoma Family of Tumors in the Head and Neck Region.
Woo CG; Lee B; Song JS; Cho KJ
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):632-639. PubMed ID: 28248728
[TBL] [Abstract][Full Text] [Related]
16. Status of methylthioadenosine phosphorylase and its impact on cellular response to L-alanosine and methylmercaptopurine riboside in human soft tissue sarcoma cells.
Li W; Su D; Mizobuchi H; Martin DS; Gu B; Gorlick R; Cole P; Bertino JR
Oncol Res; 2004; 14(7-8):373-9. PubMed ID: 15301428
[TBL] [Abstract][Full Text] [Related]
17. Methylthioadenosine phosphorylase deficiency in Japanese osteosarcoma patients.
Miyazaki S; Nishioka J; Shiraishi T; Matsumine A; Uchida A; Nobori T
Int J Oncol; 2007 Nov; 31(5):1069-76. PubMed ID: 17912432
[TBL] [Abstract][Full Text] [Related]
18. Primary Renal Ewing Sarcoma in Children and Young Adults.
Bradford K; Nobori A; Johnson B; Allen-Rhoades W; Naik-Mathuria B; Panosyan EH; Gotesman M; Lasky J; Cheng J; Ikeda A; Goldstein J; Singh A; Federman N
J Pediatr Hematol Oncol; 2020 Nov; 42(8):474-481. PubMed ID: 32282650
[TBL] [Abstract][Full Text] [Related]
19. Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases.
Machado I; Navarro L; Pellin A; Navarro S; Agaimy A; Tardío JC; Karseladze A; Petrov S; Scotlandi K; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2016 Jun; 22():25-32. PubMed ID: 27180056
[TBL] [Abstract][Full Text] [Related]
20. MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab.
Jing W; Zhu H; Liu W; Zhai X; Tian H; Yu J
Sci Rep; 2020 Jan; 10(1):843. PubMed ID: 31965001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
